Affinage

NKX2-2

Homeobox protein Nkx-2.2 · UniProt O95096

Length
273 aa
Mass
30.1 kDa
Annotated
2026-06-10
100 papers in source corpus 39 papers cited in narrative 39 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 9/9 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

NKX2-2 is a homeodomain transcription factor that interprets graded developmental signals to specify cell identity in multiple lineages, acting predominantly as a transcriptional repressor but also as a context-dependent activator (PMID:10217145, PMID:18414662, PMID:19759004). In the ventral neural tube it functions downstream of Sonic hedgehog to specify V3 interneuron fate, and together with the paralog Nkx2.9 it represses the motor neuron program (including Olig2) to establish the p3 progenitor domain (PMID:10217145, PMID:21068056); it likewise controls the timing of oligodendrocyte differentiation and maturation, in part by directly binding and repressing the Pdgfra promoter (PMID:11526078, PMID:24449836). In the pancreatic islet, NKX2-2 is required for terminal differentiation and maintenance of insulin-producing beta cells and for alpha- and epsilon-cell identity, operating downstream of Neurog3 in the endocrine progenitor lineage and upstream of Nkx6.1 (PMID:9584121, PMID:11076772, PMID:28071588, PMID:39797760). It directly occupies the insulin, IAPP, glucokinase, mafA, and NeuroD1 control regions, activating beta-cell maturation genes while repressing alternate-fate genes such as Arx and ghrelin (PMID:12426319, PMID:16847327, PMID:19759004, PMID:22056672). Repressive function is executed by recruiting corepressor complexes: the N-terminal TN (tinman) domain binds Grg3/TLE, while a C-terminal region recruits HDAC1 and DNMT3A, directing repression of methylated targets such as the Arx promoter to prevent beta-to-alpha transdifferentiation (PMID:22056672, PMID:31932307). The NK2-specific domain confers beta-cell-specific functions through interactions with chromatin remodelers and the nuclear pore complex but is dispensable for CNS roles, defining tissue-specific domain requirements (PMID:37364986). NKX2-2 also directs intestinal enteroendocrine cell fate and type III taste cell commitment (PMID:27287799, PMID:34097879). In Ewing's sarcoma, NKX2-2 is an obligatory transcriptional target and downstream effector of the EWS/FLI fusion that drives oncogenesis solely through its repressor activity, silencing differentiation, cell adhesion, and extracellular matrix genes (PMID:16697960, PMID:18414662, PMID:26000096). A frameshift mutation in the NKX2-2 homeodomain that abolishes DNA binding causes neonatal diabetes (PMID:37821536).

Mechanistic history

Synthesis pass · year-by-year structured walk · 22 steps
  1. 1998 High

    Established that NKX2-2 is required for terminal differentiation of insulin-producing beta cells, defining its first developmental requirement.

    Evidence Null mouse genetics with islet marker analysis

    PMID:9584121

    Open questions at the time
    • Did not identify direct target genes
    • Mechanism of arrest (repressor vs activator) not resolved
  2. 1999 High

    Showed NKX2-2 is a primary interpreter of graded Shh signaling in the neural tube, converting a signaling gradient into V3 interneuron identity rather than acting through Pax6.

    Evidence Nkx2.2 null mice, immunohistochemistry, epistasis with Pax6 mutants

    PMID:10217145

    Open questions at the time
    • Direct transcriptional targets in neural tube not defined
    • Did not address downstream effector genes
  3. 2000 Medium

    Defined the nuclear import determinants of NKX2-2, mapping two cooperative NLS within the homeodomain.

    Evidence Deletion mutant analysis and nuclear localization assays

    PMID:10772886

    Open questions at the time
    • Import receptors not identified at this stage
    • Single-lab functional readout
  4. 2000 High

    Placed Nkx6.1 genetically downstream of NKX2-2 in beta-cell differentiation, ordering the islet transcription factor hierarchy.

    Evidence Double-mutant mouse epistasis

    PMID:11076772

    Open questions at the time
    • Direct vs indirect regulation of Nkx6.1 unresolved
  5. 2001 High

    Demonstrated NKX2-2 cooperates with Olig2 as a repressor to drive oligodendrocyte differentiation and that it controls OL maturation in vivo.

    Evidence Ectopic expression in chick spinal cord, null mouse genetics, reporter assays

    PMID:11526078 PMID:11567617

    Open questions at the time
    • Direct OL target genes not yet identified
    • Nature of the Olig2 interaction unresolved
  6. 2003 Medium

    Showed NKX2-2 physically complexes with Olig2 and placed it upstream of serotonergic specification factors, linking protein interaction to lineage cross-repression.

    Evidence Co-IP, yeast two-hybrid, deletion mapping; ectopic expression with Lmx1b/Pet-1 in chick

    PMID:14573534 PMID:14602809

    Open questions at the time
    • Olig2 complex shown insufficient for OPC induction
    • Functional relevance of physical interaction not established
  7. 2006 High

    Identified direct NKX2-2 occupancy at islet target promoters (insulin, IAPP, pax-4, glucokinase) and at the mafA enhancer, providing the first direct binding evidence in beta cells.

    Evidence ChIP in beta cells, EMSA, reporter assays, Nkx2.2-null analysis

    PMID:12426319 PMID:16847327

    Open questions at the time
    • Cofactors at these sites not yet defined
    • Activator vs repressor mode site-specific
  8. 2006 High

    Established NKX2-2 as an obligatory downstream target of EWS/FLI required for Ewing's sarcoma tumorigenesis, extending its role beyond development to oncogenesis.

    Evidence RNAi knockdown, rescue, microarray profiling

    PMID:16697960

    Open questions at the time
    • Mechanism of transformation (repressor vs activator) not yet resolved
    • Direct oncogenic targets unidentified
  9. 2007 High

    Defined NKX2-2 repressor activity as sufficient to rescue alpha and partial beta-cell fate, and showed it is required to maintain mature beta-cell function, linking transcriptional repression to islet identity and physiology.

    Evidence Transgenic Engrailed-repressor and dominant-derivative mice, glucose tolerance/insulin secretion assays, co-IP of Grg3

    PMID:17202186 PMID:17456846 PMID:18022152

    Open questions at the time
    • Activator functions needed for full beta-cell maturation not identified
    • Distinction between developmental and maintenance targets incomplete
  10. 2008 High

    Resolved the mechanism of NKX2-2-driven transformation in Ewing's sarcoma as repression-only, mapping DNA-binding and repressor domains as essential and implicating TLE/HDAC corepressors.

    Evidence Structure-function mutagenesis, ChIP-chip, pharmacological TLE/HDAC inhibition, RNAi

    PMID:18414662

    Open questions at the time
    • Specific repressed differentiation targets not fully enumerated here
  11. 2009 High

    Revealed NKX2-2 dual activity in islet cells: direct cooperative activation of NeuroD1 with Ngn3 and direct binding/regulation of the ghrelin promoter.

    Evidence ChIP, EMSA, reporter assays, KO mouse and zebrafish knockdown

    PMID:19759004 PMID:19965928

    Open questions at the time
    • Switch between activation and repression modes mechanistically unexplained
    • Cofactor determinants of mode not identified
  12. 2011 High

    Assembled the NKX2-2 corepressor complex (DNMT3a, Grg3, HDAC1) and showed TN-domain recruitment of Grg3 directs Arx-promoter repression to prevent beta-to-alpha transdifferentiation, mechanistically linking corepressor recruitment to cell-identity maintenance.

    Evidence Co-IP, ChIP, TN-domain knock-in mice, DNMT3a beta-cell KO, Arx conditional rescue

    PMID:21856296 PMID:22056672

    Open questions at the time
    • How DNA methylation status is established at targets unresolved
    • Full complex stoichiometry not defined
  13. 2011 Medium

    Extended the HDAC1-dependent repression mechanism to oligodendroglia, showing NKX2-2 represses Sirt2 via HDAC1 to time differentiation.

    Evidence ChIP, HDAC1 RNAi, overexpression in CG4 cells

    PMID:21669943

    Open questions at the time
    • Single-lab cell-line evidence
    • In vivo relevance of Sirt2 regulation untested
  14. 2014 High

    Identified Pdgfra as a direct NKX2-2 repression target acting as a timing switch for oligodendrocyte differentiation.

    Evidence ChIP, conditional KO and OE in OPCs, genetic epistasis with Pdgfra KO

    PMID:24449836

    Open questions at the time
    • Corepressors at Pdgfra promoter not defined
  15. 2015 Medium

    Showed NKX2-2 represses cell adhesion and ECM genes (including zyxin) in Ewing's sarcoma, linking its repressor activity to control of migration and adhesion.

    Evidence RNA-seq after knockdown, adhesion/migration assays, immunofluorescence

    PMID:26000096

    Open questions at the time
    • Direct binding to adhesion gene loci not all confirmed
    • Single lab
  16. 2016 Medium

    Identified the importins (alpha1, beta1, importin 13) mediating NKX2-2 nuclear import and the differential NLS dependence among pathways.

    Evidence GST pulldown, in vitro import assays, importin RNAi, NLS mutagenesis

    PMID:27956177

    Open questions at the time
    • In vivo redundancy of import pathways untested
    • Single lab in vitro
  17. 2016 High

    Defined NKX2-2 control of intestinal enteroendocrine fate at multiple stages, placing Lmx1a downstream in the enterochromaffin/serotonin program.

    Evidence Stage-specific conditional KO, lineage tracing, Lmx1a KO

    PMID:27287799

    Open questions at the time
    • Direct intestinal target genes not mapped
  18. 2017 High

    Demonstrated NKX2-2 has essential, stage-specific functions within the Neurog3+ endocrine progenitor population, distinct from earlier pancreatic progenitor roles.

    Evidence Neurog3-Cre conditional KO vs germline null, expression analysis

    PMID:28071588

    Open questions at the time
    • Stage-specific direct targets not delineated
  19. 2020 High

    Mapped domain-specific corepressor recruitment in oligodendrocytes: TN domain to GRG3, C-terminus to HDAC1/DNMT3A, with synergy and intramolecular suppression by the NK2 domain.

    Evidence Co-IP, in ovo electroporation, domain deletion analysis

    PMID:31932307

    Open questions at the time
    • Direct OL targets of each domain not enumerated
  20. 2021 High

    Identified NKX2-2 as the commitment factor for the type III taste cell lineage in posterior taste papillae, broadening its lineage-specification roles.

    Evidence Lineage tracing, KO analysis, single-cell RNA-seq, in situ hybridization

    PMID:34097879

    Open questions at the time
    • Direct taste-lineage target genes unknown
  21. 2023 High

    Established tissue-specific domain requirement: the NK2-specific domain is essential for beta-cell maturation (its mutation causes neonatal diabetes) but dispensable for CNS roles, and acts via chromatin remodeler and nuclear pore interactions.

    Evidence Endogenous SD point-mutant knock-in mice, expression analysis, co-IP; and disease-mutation functional assays

    PMID:37364986 PMID:37821536

    Open questions at the time
    • Identity of SD-dependent chromatin remodelers not fully defined in the SD study
    • Disease mutation evidence from a single case
  22. 2025 High

    Defined NKX2-2 cofactor logic for alpha-cell identity (KLF4 directs its promoter occupancy and chromatin accessibility) and beta-cell repression (CHD4 cooperates to silence non-beta genes), revealing how cofactors steer target selection.

    Evidence ChIP-seq, ATAC-seq, conditional KO and OE; proteomics, co-IP, conditional KO, calcium imaging (CHD4 preprint)

    PMID:39797760 PMID:40667117

    Open questions at the time
    • CHD4 findings are from a preprint not yet peer-reviewed
    • How cofactor availability is set per cell type unresolved

Open questions

Synthesis pass · forward-looking unresolved questions
  • How NKX2-2 switches between repressor and activator modes at individual loci, and how cofactor/chromatin context selects tissue-specific target sets, remains incompletely defined.
  • No unifying biochemical model for activator-vs-repressor switching
  • Structural basis of domain-specific cofactor selection unresolved
  • Genome-wide direct targets across all lineages not comprehensively integrated

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 6 GO:0003677 DNA binding 3
Localization
GO:0005654 nucleoplasm 3 GO:0005634 nucleus 2
Pathway
R-HSA-1266738 Developmental Biology 6 R-HSA-1643685 Disease 4 R-HSA-74160 Gene expression (Transcription) 4 R-HSA-4839726 Chromatin organization 3
Partners
CHD4DNMT3AHDAC1IMPORTIN BETA1KLF4OLIG2TLE/GRG3
Complex memberships
HDAC1-mSin3A corepressor complexNKX2-2-Grg3-HDAC1-DNMT3A corepressor complex

Evidence

Reading pass · 39 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1999 Nkx2.2 is required downstream of graded Sonic hedgehog signaling to specify ventral neuronal identity in the neural tube; in Nkx2.2 mutant mice, progenitor cells that normally form V3 interneurons instead generate motor neurons, while Pax6 expression remains unchanged, placing Nkx2.2 as a primary interpreter of graded Shh signals rather than an indirect effector of Pax6. Loss-of-function mouse genetics (Nkx2.2 null mutants), immunohistochemistry, epistasis analysis with Pax6 mutants Nature High 10217145
1998 Nkx2.2 is required for the final differentiation of pancreatic beta cells; mice lacking Nkx2.2 completely lack insulin-producing beta cells and have reduced alpha and PP cells, with remaining islet cells expressing some but not all beta cell markers (e.g., IAPP and Pdx1 present, but Glut2 and Nkx6.1 absent), indicating beta cells are arrested in an incompletely differentiated state. Null mouse genetics, immunohistochemistry, marker expression analysis Development High 9584121
2001 Co-expression of Nkx2.2 and Olig2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation; both proteins function as transcriptional repressors in this assay, and forced Neurogenin1 expression blocks this cooperative effect. Ectopic expression in chick spinal cord (electroporation), reporter assays, epistasis with Neurogenin1 Neuron High 11567617
2000 Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell differentiation; Nkx6.1/Nkx2.2 double mutant islet development is identical to Nkx2.2 single mutant development (beta-cell precursors survive but fail to differentiate), establishing Nkx6.1 downstream of Nkx2.2. Double-mutant mouse genetics, epistasis analysis, immunohistochemistry Development High 11076772
2001 Nkx2.2 regulates the differentiation and maturation (but not initial specification) of oligodendrocyte progenitors in the rodent CNS; Nkx2.2-null mutants show dramatically retarded MBP+ and PLP-DM20+ oligodendrocyte differentiation along the entire rostrocaudal axis, while astrocytic differentiation is unaffected. Additionally, absence of Nkx2.2 causes ventral expansion of Olig1/Olig2 expression. Loss-of-function mouse genetics (Nkx2.2 null), immunohistochemistry, overexpression in fibroblasts (PLP promoter reporter) Development High 11526078
2006 NKX2.2 is a transcriptional target of the EWS/FLI fusion protein in Ewing's sarcoma and is necessary for the oncogenic transformation phenotype; knockdown of NKX2.2 by RNAi in Ewing's sarcoma cells abrogates tumorigenic properties. Retroviral RNAi knockdown, reexpression rescue, microarray expression profiling Cancer Cell High 16697960
2008 NKX2.2 mediates oncogenic transformation in Ewing's sarcoma solely through transcriptional repression: its DNA-binding and repressor domains are required for oncogenesis while its transcriptional activation domain is dispensable. NKX2.2 recruits TLE (Groucho) and HDAC co-repressors, and blockade of TLE or HDAC function inhibits the transformed phenotype. ChIP-chip shows NKX2.2 directly binds and represses target genes. Structure-function mutagenesis, microarray, ChIP-chip, pharmacological inhibition of TLE/HDAC, RNAi PLoS One High 18414662
2011 Nkx2.2 is part of a large repression complex in pancreatic beta cells that includes DNMT3a, Grg3, and HDAC1. The TN (tinman) domain of Nkx2.2 is required for interaction with Grg3; mutation of the TN domain abolishes Grg3 interaction, disrupts beta-cell specification, and causes ectopic Arx expression leading to beta-to-alpha cell transdifferentiation. Nkx2.2 preferentially recruits Grg3 and HDAC1 to the methylated Arx promoter in beta cells. Subsequent removal of Arx in TN-mutant mice reverts the beta-to-alpha cell conversion. Co-immunoprecipitation, ChIP, endogenous TN-domain point mutation knock-in mice, DNMT3a beta-cell-specific KO, Arx conditional deletion rescue Genes & Development High 22056672
2014 Nkx2.2 directly binds to the Pdgfra promoter and represses its expression, thereby acting as a timing switch for oligodendrocyte differentiation. Induced Nkx2.2 expression in early OPCs causes precocious oligodendrocyte differentiation; conditional ablation delays maturation. Genetic ablation of Pdgfra mimics Nkx2.2 overexpression in accelerating OPC differentiation. ChIP, conditional KO, gain-of-function overexpression in OPCs, genetic epistasis with Pdgfra KO Development High 24449836
2003 Nkx2.2 forms a physical protein complex with Olig2 in mammalian cells and in yeast two-hybrid assay; this interaction is specific (Olig2 does not bind Nkx6.1; Nkx2.2 does not bind NeuroD). Deletion mapping showed the physical complex is insufficient for oligodendrocyte progenitor induction but may mediate the cross-repressive interaction establishing the pMN-p3 boundary. Co-immunoprecipitation in mammalian cells, yeast two-hybrid, deletion mapping Journal of Neuroscience Medium 14573534
2003 Lmx1b and Pet-1 act downstream of Nkx2.2 in specifying the serotonergic (5-HT) neurotransmitter phenotype; combined ectopic expression of Lmx1b, Pet-1, and Nkx2.2 drives 5-HT differentiation in the dorsal spinal cord where Nkx2.2 is normally expressed, establishing a molecular pathway sufficient to specify serotonergic identity. Loss-of-function mouse genetics (Lmx1b null, Nkx2.2 null), ectopic expression in chick spinal cord, epistasis analysis Journal of Neuroscience High 14602809
2004 Pax4 genetically interacts with Nkx2.2 to initiate pancreatic beta-cell differentiation; loss of Pax4 prevents expression of Pdx1, HB9, and insulin in beta-cell precursors, and this role is accomplished via genetic interaction with Nkx2.2. Loss-of-function mouse genetics (Pax4 KO), immunohistochemistry, epistasis analysis with Nkx2.2 Developmental Biology Medium 14729487
2005 Nkx2.2 represses myelin basic protein (MBP) gene expression in oligodendrocyte progenitors by binding two regulatory elements in the MBP promoter, blocking Puralpha binding, and recruiting an HDAC1-mSin3A co-repressor complex; the transcription factor Sp1 competes off Nkx2.2 from its binding site and reverses this repression. In vitro DNA binding assay (EMSA), reporter assays, co-immunoprecipitation, chromatin immunoprecipitation Journal of Biological Chemistry High 15695521
2006 Nkx2.2 directly occupies the insulin gene control region in intact beta cells and also occupies the IAPP, pax-4, and glucokinase control sequences in vivo. In vitro DNA-binding and transient transfection assays confirmed Nkx2.2 binding and its effect on insulin gene expression. Chromatin immunoprecipitation (ChIP) in beta cells, EMSA, transient transfection reporter assays Journal of Biological Chemistry High 12426319
2006 PDX-1, FoxA2, and Nkx2.2 directly bind to the conserved region 3 (bp -8118 to -7750) of the mafA promoter in vivo, and Nkx2.2 mediates activation of this region; MafA expression is undetected in Nkx2.2-null pancreas. ChIP, reporter assays with mutational analysis, siRNA knockdown, Nkx2.2 null mouse analysis Molecular and Cellular Biology High 16847327
2007 Nkx2.2-repressor activity (Nkx2.2-Engrailed repressor derivative) is sufficient to fully rescue glucagon-producing alpha-cells and partially rescue insulin-producing beta-cells in Nkx2.2-null mice. Insulin-positive rescued cells lack mature beta-cell markers MafA and Glut2, indicating additional activator functions are required for maturation. Grg3 is highly expressed in embryonic pancreas and physically interacts with Nkx2.2 through its TN domain. Transgenic dominant-derivative mouse lines, immunohistochemistry, co-immunoprecipitation Development High 17202186
2007 Nkx2.2 is required for maintenance and function of the mature beta cell; expressing a repressor derivative of Nkx2.2 in mature beta cells disrupts endogenous Nkx2.2 and causes downregulation of MafA and Glut2, reduced insulin gene expression and pancreatic insulin content, impaired insulin secretion, and glucose intolerance. Transgenic mice expressing Nkx2.2-repressor derivative in mature beta cells, glucose tolerance tests, insulin secretion assays, marker expression analysis Diabetes Medium 17456846
2007 Nkx2.2 regulates cell fate choices within the intestinal enteroendocrine population; Nkx2.2-null mice lack or have reduced several hormone-producing enteroendocrine cell populations with a corresponding increase in ghrelin cells, and Nkx2.2 appears to function upstream of Pax6 in intestinal cell fate (Pax6 expression is decreased in Nkx2.2-null intestine). Nkx2.2 null mouse genetics, immunohistochemistry, marker expression analysis, epistasis with Pax6 Developmental Biology Medium 18022152
2009 Nkx2.2 cooperatively activates NeuroD1 transcription with Ngn3 in endocrine progenitor cells and maintains NeuroD1 expression in mature beta cells. Nkx2.2 regulates NeuroD1 through two independent promoter elements: one directly bound and activated by Nkx2.2, and one regulated indirectly. Nkx2.2 activity is required to facilitate Ngn3-mediated NeuroD1 activation. Reporter assays, ChIP, Nkx2.2 KO mouse analysis, zebrafish knockdown, promoter deletion analysis Journal of Biological Chemistry High 19759004
2009 Nkx2.2 can bind to and activate the ghrelin promoter; the region -619 to -488 bp upstream of the translational start site is necessary for repression of ghrelin in alphaTC1 and betaTC6 cells. Upregulation of ghrelin in Nkx2.2-null mice is not due to loss of ghrelin promoter repression in non-ghrelin islet cells. Reporter assays, ChIP, EMSA, Nkx2.2 null mouse analysis Molecular Endocrinology Medium 19965928
2011 Nkx2.2 transcription factor binds to the Sirt2 promoter via HDAC-1 in oligodendroglial precursor cells and negatively regulates Sirt2 expression. HDAC-1 knockdown attenuates Nkx2.2 binding capacity and releases Sirt2 repression. Nkx2.2 overexpression down-regulates Sirt2 and delays CG4 cell differentiation. ChIP, HDAC-1 RNAi, Nkx2.2 overexpression in CG4 oligodendroglial precursor cells Journal of Molecular Cell Biology Medium 21669943
2000 The homeodomain of Nkx2.2 contains two cooperatively acting monopartite nuclear localization signals (NLS): proximal NLS (KKRKRR) at the N-terminus of the homeodomain and distal NLS (RYKMKRAR) at its C-terminus. Each NLS alone is sufficient but inefficient for nuclear transport; both act cooperatively for complete nuclear import. Deletion mutant analysis, nuclear localization assays Biochemical and Biophysical Research Communications Medium 10772886
2016 Nuclear import of Nkx2-2 is mediated by multiple pathways: importin α1 interacts with Nkx2-2 and transports it together with importin β1 in vitro; importin β1 and importin 13 also directly interact with Nkx2-2 and transport it in vitro. Mutation of NLS1 or NLS2 has no effect on interaction with importin α1 or importin 13, but significantly reduces binding to importin β1. GST pulldown, in vitro nuclear import assay, importin β1 RNAi, Bimax2 overexpression, NLS mutagenesis Biochemical and Biophysical Research Communications Medium 27956177
2017 Nkx2.2 acts downstream of Neurog3 in the endocrine progenitor lineage for beta cell differentiation; conditional ablation of Nkx2.2 specifically in Neurog3+ progenitors recapitulates the Nkx2.2 null beta cell phenotype despite maintenance of many beta cell transcriptional network components, demonstrating Nkx2.2 has essential activities within the endocrine progenitor population beyond its earlier pancreatic progenitor role. Conditional KO using Neurog3-Cre, comparison with germline Nkx2.2 null, gene expression analysis eLife High 28071588
2010 In mice lacking both Nkx2.2 and Nkx2.9, the presumptive p3 domain progenitors convert to motor neurons and never acquire V3 interneuron fate, demonstrating that Nkx2 transcription factors repress the motor neuron lineage program (including Olig2) to establish V3 progenitor cells. Additionally, combined loss of Nkx2.2 and Nkx2.9 results in a smaller and functionally impaired floor plate causing severe commissural axon pathfinding defects. Double-mutant mouse genetics, lineage analysis, electrophysiology, immunohistochemistry Development High 21068056
2020 NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with distinct transcriptional corepressors: the N-terminal Tinman (TN) domain recruits GRG3, and the C-terminal domain recruits HDAC1 and DNMT3A. Both domains synergistically promote OL differentiation in vivo. The NK2-specific domain suppresses the function of the C-terminal domain in OL differentiation. Coimmunoprecipitation, in ovo electroporation in chick spinal cord, immunofluorescence, domain deletion analysis Journal of Biological Chemistry High 31932307
2011 Nkx2.2 and Arx genetically interact in pancreatic endocrine progenitors; in the Nkx2.2-null context, Arx is necessary for upregulation of ghrelin mRNA in epsilon cells but not for the expansion of the ghrelin cell population. In the absence of Arx, Nkx2.2 becomes essential for repression of somatostatin gene expression, and Arx is required in Neurog3+ endocrine progenitors. Compound conditional KO mouse genetics (Nkx2.2 null; Arx conditional deletion), immunohistochemistry, gene expression analysis Developmental Biology Medium 21856296
2014 Ceramide galactosyltransferase (CGT) expression in oligodendrocytes is positively regulated by Nkx2.2 at the promoter level; Nkx2.2 strongly activates the CGT promoter in reporter assays, and this activation is cancelled by co-expression of OLIG2, which binds a repressive element in the first intron of CGT. Reporter assay (luciferase), transcription factor co-expression in oligodendroglioma cells, identification of binding element Glycobiology Low 24821492
2016 Nkx2.2 regulates enteroendocrine cell specification at multiple stages in the intestine; serotonin-producing enterochromaffin cells are most severely reduced in all Nkx2.2 mutant conditions. The transcription factor Lmx1a is expressed in enterochromaffin cells downstream of Nkx2.2, and Lmx1a-deficient mice have reduced expression of Tph1, the rate-limiting enzyme for serotonin biosynthesis. Stage- and cell type-specific Nkx2.2 conditional KO, lineage tracing, Lmx1a KO mouse analysis Development High 27287799
2023 The NK2-specific domain (SD) of NKX2.2 is required for beta cell-specific functions: SD mutation in mice prevents developmental progression of beta cell precursors into mature insulin-expressing beta cells, causing neonatal diabetes, and impairs a subset of adult beta cell gene expression programs. However, the SD is entirely dispensable for NKX2.2-dependent CNS cell type development, demonstrating tissue-specific domain requirement. SD-dependent interactions occur with components of chromatin remodelers and the nuclear pore complex. Endogenous SD point-mutation knock-in mice, gene expression analysis, co-immunoprecipitation for chromatin remodeler interactions Genes & Development High 37364986
2025 NKX2.2 is critical for pancreatic alpha cell identity by directly activating alpha-cell genes and repressing alternate islet cell fate genes. KLF4 is enriched in alpha cells, co-occupies NKX2.2-bound alpha-cell promoters, is necessary for NKX2.2 promoter occupancy in alpha cells, and co-regulates NKX2.2 alpha-cell transcriptional targets. Overexpression of Klf4 in beta cells is sufficient to manipulate chromatin accessibility and increase NKX2.2 binding at alpha-cell-specific promoter sites. ChIP-seq, ATAC-seq, conditional KO (Nkx2.2 and Klf4), Klf4 overexpression in beta cells, gene expression analysis Genes & Development High 39797760
2025 CHD4 (chromodomain helicase DNA-binding protein 4) is an NKX2.2 interacting partner in beta cells identified by proteomics; CHD4 and NKX2.2 cooperatively bind to and repress non-beta cell genes, including Kcnj5 (encoding GIRK4 potassium channel). Deletion of Chd4 in beta cells causes diabetes with disrupted islet integrity, impaired calcium signaling, and downregulation of beta cell regulatory genes; aberrant GIRK4 expression causes impaired glucose-stimulated insulin secretion. Unbiased proteomics screen, co-immunoprecipitation, Chd4 conditional KO (beta-cell specific), ChIP, calcium imaging, glucose-stimulated insulin secretion assay bioRxivpreprint Medium 40667117
2024 NKX2-2 represses proneural gene NEUROG2 by two distinct mechanisms in rodent versus human spinal progenitors: in rodents, NKX2-2 represses Olig2 and the motor neuron lineage through its tinman domain (leading to loss of Neurog2); in human vpMN progenitors, NKX2-2 represses NEUROG2 but not OLIG2, allowing motor neurogenesis to proceed in a delayed manner. Ectopic expression of tinman-mutant Nkx2-2 in mouse pMNs phenocopies human vpMNs. In vivo and in vitro gain/loss-of-function, ectopic expression of tinman domain mutants in mouse, comparative human vs rodent neural progenitor analysis bioRxivpreprint Medium 39415990
2015 In Ewing's sarcoma, NKX2-2 represses cell adhesion and extracellular matrix organization genes; NKX2-2-depleted cells form more focal adhesions, organized actin stress fibers, spread over wider area, and display increased migration and substrate adhesion. NKX2-2 specifically represses the actin-stabilizing protein zyxin. RNA-seq after NKX2-2 knockdown, cell adhesion/migration assays, immunofluorescence for actin and focal adhesions Genes & Cancer Medium 26000096
2010 NKX2.2 overexpression in glioblastoma-derived glioma-initiating cells (GICs) induces oligodendroglial differentiation and suppresses self-renewal capacity; conversely, Nkx2.2 downregulation in mouse neural progenitor cells accelerates GBM formation. Downregulation of NKX2.2 correlates with increased tumor malignancy in both mouse models and human specimens. Overexpression in GICs, loss-of-function in mouse NPCs (in vivo), neurosphere self-renewal assays, differentiation marker analysis Cancer Research Medium 21169405
2024 Nkx2.2 and Zfp488 act as transcriptional activators (in addition to their known repressor roles) for the G protein-coupled receptor Gpr37 in differentiating oligodendrocytes; both transcription factors bind a regulatory region downstream of the Gpr37 gene in vivo and cooperate with Sox10 to activate Gpr37 expression, which modulates myelination. Overexpression in CG4 cells, Nkx2.2-deficient mouse analysis, ChIP for in vivo binding, reporter assays Glia Medium 38546197
2021 Nkx2-2-expressing taste cells in endoderm-derived circumvallate and foliate papillae are committed to the type III taste cell lineage; Nkx2-2 knockout neonatal mice do not express key type III taste cell marker genes, while type I and II marker genes are unaffected. Lineage tracing showed Nkx2-2+ cells differentiate into type III but not type II or I cells in posterior taste papillae. Conditional lineage tracing (Nkx2-2-Cre), Nkx2-2 KO mouse analysis, single-cell RNA-seq, in situ hybridization, immunostaining Developmental Biology High 34097879
2014 Nkx2.2-expressing perineurial glia in mice are CNS-derived and essential for motor nerve development and Schwann cell differentiation; in mice lacking Nkx2.2, motor nerve development is impaired. Nkx2.2:EGFP transgenic reporter, Nkx2.2 null mouse analysis, RNA expression analysis, antibody labeling Developmental Dynamics Medium 24979729
2023 A frameshift mutation (c.772delC, p.Q258SFs*59) in the NKX2-2 homeodomain results in an elongated protein that lacks normal DNA binding activity and transcriptional function, establishing that DNA binding by NKX2-2 is required for its normal transcription factor activity. Structural analysis indicated alterations in tertiary structure contributing to dysfunction. Functional transactivation assay, DNA binding assay, nuclear localization assay, protein structural modeling of mutant Acta Diabetologica Medium 37821536

Source papers

Stage 0 corpus · 100 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1999 Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. Nature 605 10217145
1998 Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development (Cambridge, England) 513 9584121
2001 The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 478 11567617
2000 Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development (Cambridge, England) 427 11076772
2001 Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development (Cambridge, England) 315 11526078
2006 Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer cell 297 16697960
2004 Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Molecular and cellular neurosciences 245 15519240
2002 Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation. Development (Cambridge, England) 177 11830569
2011 Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming. Genes & development 165 22056672
2005 Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Experimental neurology 162 15698615
2012 NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. The American journal of surgical pathology 157 22446943
2017 Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development. eLife 156 28071588
2016 Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 148 26847175
2003 Lmx1b, Pet-1, and Nkx2.2 coordinately specify serotonergic neurotransmitter phenotype. The Journal of neuroscience : the official journal of the Society for Neuroscience 140 14602809
2014 Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS. Development (Cambridge, England) 125 24449836
1997 Expression patterns of Brx1 (Rieg gene), Sonic hedgehog, Nkx2.2, Dlx1 and Arx during zona limitans intrathalamica and embryonic ventral lateral geniculate nuclear formation. Mechanisms of development 121 9347917
2008 EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma. PloS one 119 18414662
2001 Distinct sites of origin of oligodendrocytes and somatic motoneurons in the chick spinal cord: oligodendrocytes arise from Nkx2.2-expressing progenitors by a Shh-dependent mechanism. Development (Cambridge, England) 119 11262237
2004 The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic beta-cell differentiation. Developmental biology 117 14729487
2014 Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man. Cell metabolism 114 24411943
2006 FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site. Molecular and cellular biology 102 16847327
2014 The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Archiv : an international journal of pathology 87 25031013
2007 Nkx2.2 regulates beta-cell function in the mature islet. Diabetes 85 17456846
2002 Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx2.2. The Journal of biological chemistry 81 12426319
2010 Co-localization of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes. Glia 80 19780200
2007 Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine. Developmental biology 80 18022152
2010 Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma. BMC cancer 71 21059263
2008 Nkx2.2 antisense RNA overexpression enhanced oligodendrocytic differentiation. Biochemical and biophysical research communications 71 18538132
2011 Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation. Journal of molecular cell biology 67 21669943
2004 Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia 63 15048854
2007 Nkx2.2-repressor activity is sufficient to specify alpha-cells and a small number of beta-cells in the pancreatic islet. Development (Cambridge, England) 61 17202186
2005 Stage-specific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the Sp1 transcription factor. The Journal of biological chemistry 60 15695521
2006 Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. Journal of neuropathology and experimental neurology 59 17146289
2003 Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex. The Journal of neuroscience : the official journal of the Society for Neuroscience 55 14573534
2018 NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls. Cancer cytopathology 51 30376220
2009 Cooperative transcriptional regulation of the essential pancreatic islet gene NeuroD1 (beta2) by Nkx2.2 and neurogenin 3. The Journal of biological chemistry 51 19759004
2003 Co-expression pattern of Shh with Prox1 and that of Nkx2.2 with Mash1 in mouse taste bud. Gene expression patterns : GEP 45 12915306
2016 The novel enterochromaffin marker Lmx1a regulates serotonin biosynthesis in enteroendocrine cell lineages downstream of Nkx2.2. Development (Cambridge, England) 43 27287799
2010 The transcription factors Nkx2.2 and Nkx2.9 play a novel role in floor plate development and commissural axon guidance. Development (Cambridge, England) 42 21068056
2015 EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma. Genes & cancer 40 26000096
2011 Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression. Developmental biology 40 21856296
2017 Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors. Head and neck pathology 38 28616785
2005 Differentiation of embryonic stem cells into insulin-producing cells promoted by Nkx2.2 gene transfer. World journal of gastroenterology 36 16015683
2014 Mammalian Nkx2.2+ perineurial glia are essential for motor nerve development. Developmental dynamics : an official publication of the American Association of Anatomists 35 24979729
2008 Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. Endocrine-related cancer 32 18987169
2020 The transcription factor NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with transcriptional corepressors. The Journal of biological chemistry 28 31932307
2009 Identification of known and novel pancreas genes expressed downstream of Nkx2.2 during development. BMC developmental biology 27 20003319
2017 Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors. Pathology, research and practice 26 28864350
2011 Arx and Nkx2.2 compound deficiency redirects pancreatic alpha- and beta-cell differentiation to a somatostatin/ghrelin co-expressing cell lineage. BMC developmental biology 25 21880149
2014 C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2. PloS one 24 24835010
2013 Generation of mice encoding a conditional allele of Nkx2.2. Transgenic research 24 23494546
2010 NKX2.2 suppresses self-renewal of glioma-initiating cells. Cancer research 23 21169405
2011 Ontogenetic distribution of the transcription factor nkx2.2 in the developing forebrain of Xenopus laevis. Frontiers in neuroanatomy 22 21415915
2018 NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors. Biomarker research 20 29713473
2013 Nkx2.2:Cre knock-in mouse line: a novel tool for pancreas- and CNS-specific gene deletion. Genesis (New York, N.Y. : 2000) 20 23996959
2015 Nkx2.2 is expressed in a subset of enteroendocrine cells with expanded lineage potential. American journal of physiology. Gastrointestinal and liver physiology 19 26492922
2003 Undulated short-tail deletion mutation in the mouse ablates Pax1 and leads to ectopic activation of neighboring Nkx2-2 in domains that normally express Pax1. Genetics 18 14504237
2000 The homeodomain of Nkx2.2 carries two cooperatively acting nuclear localization signals. Biochemical and biophysical research communications 17 10772886
2018 NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma. Oncotarget 16 30680064
2018 NKX2-2 Suppresses Osteosarcoma Metastasis and Proliferation by Downregulating Multiple Target Genes. Journal of Cancer 15 30210629
2015 Nkx2.2 and Nkx2.9 are the key regulators to determine cell fate of branchial and visceral motor neurons in caudal hindbrain. PloS one 15 25919494
2012 Generation of Nkx2.2:lacZ mice using recombination-mediated cassette exchange technology. Genesis (New York, N.Y. : 2000) 15 22539496
2009 Nkx2.2 activates the ghrelin promoter in pancreatic islet cells. Molecular endocrinology (Baltimore, Md.) 15 19965928
2015 Regulation of the Human Ghrelin Promoter Activity by Transcription Factors, NF-κB and Nkx2.2. International journal of endocrinology 14 25699080
2020 NKX2-2 Mutation Causes Congenital Diabetes and Infantile Obesity With Paradoxical Glucose-Induced Ghrelin Secretion. The Journal of clinical endocrinology and metabolism 13 32818257
2014 Nato3 plays an integral role in dorsoventral patterning of the spinal cord by segregating floor plate/p3 fates via Nkx2.2 suppression and Foxa2 maintenance. Development (Cambridge, England) 13 24401371
2009 Spatially distinct functions of PAX6 and NKX2.2 during gliogenesis in the ventral spinal cord. Biochemical and biophysical research communications 12 19258013
2023 Major β cell-specific functions of NKX2.2 are mediated via the NK2-specific domain. Genes & development 11 37364986
2022 Gata2, Nkx2-2 and Skor2 form a transcription factor network regulating development of a midbrain GABAergic neuron subtype with characteristics of REM-sleep regulatory neurons. Development (Cambridge, England) 11 35815619
2014 Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2. Glycobiology 11 24821492
2007 Nkx2.2 expression in differentiation of oligodendrocyte precursor cells and inhibitory factors for differentiation of oligodendrocytes after traumatic spinal cord injury. Journal of neurotrauma 11 17600517
2021 Nkx2-2 expressing taste cells in endoderm-derived taste papillae are committed to the type III lineage. Developmental biology 10 34097879
2010 Genetically-defined lineage tracing of Nkx2.2-expressing cells in chick spinal cord. Developmental biology 10 20951692
2011 Novel computational analysis of protein binding array data identifies direct targets of Nkx2.2 in the pancreas. BMC bioinformatics 9 21352540
2012 Ectopic transgenic expression of NKX2.2 induces differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell cycle (Georgetown, Tex.) 8 22433950
2015 Generation of a Nkx2.2(Cre) knock-in mouse line: Analysis of cell lineages in the central nervous system. Differentiation; research in biological diversity 7 25840610
2015 Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma. Journal of cytology 7 25948942
2024 The myelination-associated G protein-coupled receptor 37 is regulated by Zfp488, Nkx2.2, and Sox10 during oligodendrocyte differentiation. Glia 6 38546197
2021 Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity. Cureus 6 34584801
2020 Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development. Current cancer drug targets 6 29295693
2010 Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site. The Journal of surgical research 6 20599218
2025 NKX2.2 and KLF4 cooperate to regulate α-cell identity. Genes & development 5 39797760
2023 Expression of NKX2.2 in Non-Ewing Tumors With Round Cell Morphology. Cureus 5 38234938
2020 Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids. Stem cells translational medicine 5 32716131
2016 Nuclear import of Nkx2-2 is mediated by multiple pathways. Biochemical and biophysical research communications 5 27956177
2024 NKX2-2 based nuclei sorting on frozen human archival pancreas enables the enrichment of islet endocrine populations for single-nucleus RNA sequencing. BMC genomics 4 38689254
2023 Correlation NKX2.2 IHC and EWSR1 break-apart FISH in the diagnosis of Ewing sarcoma: Can combined NKX2.2 and CD99 immunoexpression obviate or minimize the need of FISH testing? First assessment study from Indian tertiary cancer care center. Indian journal of pathology & microbiology 4 36656211
2012 Nkx2.2+ progenitors generate somatic motoneurons in the chick spinal cord. PloS one 4 23284718
2025 Clinicopathologic Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology. Archives of pathology & laboratory medicine 3 38649148
2024 Differential regulation of Shh-Gli1 cell signalling pathway on homeodomain transcription factors Nkx2.2 and Pax6 during the medulloblastoma genesis. Molecular biology reports 3 39460795
2023 CD99 and NKX2.2 positive neuroblastoma diagnosed on cytology: A potential diagnostic pitfall and necessity of pathological evaluation of the primary site. Diagnostic cytopathology 3 36999306
2023 Role of Gltp in Maturation of Oligodendrocytes Under the Regulation of Nkx2.2. Molecular neurobiology 3 37191854
2023 Differential use of the Nkx2.2 NK2 domain in developing pancreatic islets and neurons. Genes & development 3 37399332
2022 The Roles of Different Multigene Combinations of Pdx1, Ngn3, Sox9, Pax4, and Nkx2.2 in the Reprogramming of Canine ADSCs Into IPCs. Cell transplantation 3 35236160
2025 CHD4 and NKX2.2 Cooperate to Regulate Beta Cell Function by Repressing Non-Beta Cell Gene Programs. bioRxiv : the preprint server for biology 1 40667117
2023 Enrichment of human embryonic stem cell-derived V3 interneurons using an Nkx2-2 gene-specific reporter. Scientific reports 1 36737643
2023 A novel stop-loss mutation in NKX2-2 gene as a cause of neonatal diabetes mellitus: molecular characterization and structural analysis. Acta diabetologica 1 37821536
2022 [Expression and diagnostic value of NKX3.1 and NKX2.2 in mesenchymal chondrosarcoma]. Zhonghua bing li xue za zhi = Chinese journal of pathology 1 35152629
2024 Independent control of neurogenesis and dorsoventral patterning by NKX2-2. bioRxiv : the preprint server for biology 0 39415990
2022 Homeodomain Transcription Factors Nkx2.2 and Pax6 as Novel Biomarkers for Meningioma Tumor Treatment. Indian journal of clinical biochemistry : IJCB 0 38223000

Missed literature

Know a paper Affinage missed for NKX2-2? Flag it for the maintainers and the community.

No submissions yet.